All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

J.W. Awori Hayanga, MD, MPH, MHL, FACS, FRCS, FCCP, FCCM

Nicholas Teman, MD
Disclosure(s): Alexion Pharmaceuticals: Consultant (Ongoing)

Presentations

1. Achieving Adequate Renal Xenograft Perfusion and Function in an LVAD Recipient with Strict Systolic and Pulse Pressure Parameters
   Imad Aljabban, MD, MMSc
    
2. Increasing Risk of Post-Heart Transplant Hospitalizations for Infection: An Analysis of Recent Trends
   Shi Nan Feng, BPSH
    
3. ECMO, CPB, and Off-Pump Lung Transplantation Impact on 10-Year Survival Outcomes
   Nicholas Kotler, BA
    
4. Sickle Cell Disease Patients Experience a Greater Risk of Post-Operative Complications Following Cardiac Valve Replacement Procedures: A National Database Study
   Ilan Yan Pesselev
    
5. Severe Obesity Is Not a Contraindication to Veno-venous Extracorporeal Support: Outcomes in Patients with BMI ≥35
   Michael Platten, MD
    
6. Recipient Obesity and Heart Sizing: Gaining a Broader Understanding Within Heart Transplantation
   Daniel K. Ragheb, MD
    
7. Development of a Clinical Risk Score for Vasoplegic Shock After Cardiopulmonary Bypass
   Travis J. Miles, MD